• Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to primary sidebar

Before Header

Call us today at (720) 328-8501Go to Prospect Life Sciences LinkedIn page Client Login

Prospect Life Sciences

Prepare to Prosper

  • WHAT WE DO
    • Devices We Make
    • NPI Services
    • Production Services
    • Fulfillment Services
    • À La Carte Services
  • HOW WE DO IT
    • Contract Manufacturing Solutions
    • Supply Chain Management
    • Quality Systems Management
    • Project Management
    • Onsite Features
    • Partnerships & Grant Support
  • THE PLS DIFFERENCE
    • Core Values
    • Our Team
    • Why People Like Us
  • NEWS & EVENTS
  • NOW HIRING
  • CONTACT US
  • What We Do
    • Devices We Make
    • NPI Services
    • Production Services
  • How We Do It
    • Supply Chain Management
    • Quality Systems Management
    • Project Management
    • Onsite Features
    • Partnerships and Grant Support
  • The PLS Difference
  • News & Events
  • Contact Us
StimSite medical device

Allotrope Medical, Inc. Earns FDA Safer Technologies Program (STeP) Designation

StimSite medical device

November 9, 2022 By //  by PLS

Congratulations to Allotrope Medical Inc. on receiving a Safer Technologies Program (STeP) designation for their StemSite surgical device. Inclusion in STeP indicates that this medical device is expected to significantly improve the safety of currently available treatments. Read the full story to learn more.

Filed Under: news

Previous Post: «Three members of the PLS team at the MPO Summit 2022 PLS Attends MPO Summit 2022
Next Post: Spinal Stabilization Technologies in LOPAIN2 Trial »

Copyright © 2023 Prospect Life Sciences · All rights reserved. View our Privacy Policy.